We found prostate adenocarcinoma (PRAD), breast cancer (BRCA) and lung adenocarcinoma (LUAD) showed the most significantly elevated expression of FOXA1 (Figure 1A, Figure S1A). This evidence concerns the gene FOXA1 and breast cancer.